QurAlis
Developing precision therapeutics for ALS and other neurodegenerative diseases, targeting novel mechanisms.
Developing precision therapeutics for ALS and other neurodegenerative diseases, targeting novel mechanisms.
Develops quantum dot lasers and optical devices including glasses that can help "low vision" patients see.
A clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative medicines for cancer and other life-threatening diseases.
Developing breakthrough therapies for rare and severe disorders.
Development of drug delivery systems which utilize nucleic acid.
Armagen ia a clinical stage biotechnology company focused on developing novel treatments for severe neurological disorders.
Actimis is a biopharmaceutical company focused on development of novel therapeutics for respiratory and inflammatory disorders such as asthma and rheumatoid arthritis.
S*BIO focuses on the discovery and clinical development of targeted drugs for the treatment of cancer.
Develops and distributes damage-, contamination-, and maintenance-free safe and high precision cell sorter with the world’s first microfluidic chip technology. Also develops other cell sorting related products.
Develops medical technologies to treat a variety of endourological conditions, including BPH, prostate cancer and kidney cancer.
Developing a library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation.
Partnering with healthcare systems to provide home infusion therapies and services.